AngioDynamics Net Interest Income from 2010 to 2026

ANGO Stock  USD 11.40  0.04  0.35%   
AngioDynamics Net Interest Income yearly trend continues to be very stable with very little volatility. Net Interest Income is likely to grow to about 1.2 M this year. Net Interest Income is the difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities. View All Fundamentals
 
Net Interest Income  
First Reported
2019-02-28
Previous Quarter
-4 K
Current Value
-102 K
Quarterly Volatility
501 K
 
Covid
 
Interest Hikes
Check AngioDynamics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AngioDynamics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 19.1 M, Interest Expense of 1.7 M or Total Revenue of 249.7 M, as well as many indicators such as Price To Sales Ratio of 2.44, Dividend Yield of 0.0 or PTB Ratio of 2.16. AngioDynamics financial statements analysis is a perfect complement when working with AngioDynamics Valuation or Volatility modules.
  
Build AI portfolio with AngioDynamics Stock
Check out the analysis of AngioDynamics Correlation against competitors.
To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.
Evaluating AngioDynamics's Net Interest Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into AngioDynamics's fundamental strength.

Latest AngioDynamics' Net Interest Income Growth Pattern

Below is the plot of the Net Interest Income of AngioDynamics over the last few years. It is the difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities. AngioDynamics' Net Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AngioDynamics' overall financial position and show how it may be relating to other accounts over time.
Net Interest Income10 Years Trend
Slightly volatile
   Net Interest Income   
       Timeline  

AngioDynamics Net Interest Income Regression Statistics

Arithmetic Mean(1,857,080)
Coefficient Of Variation(111.92)
Mean Deviation1,816,611
Median(2,839,000)
Standard Deviation2,078,391
Sample Variance4.3T
Range6.7M
R-Value0.81
Mean Square Error1.6T
R-Squared0.66
Significance0.000078
Slope333,829
Total Sum of Squares69.1T

AngioDynamics Net Interest Income History

20261.2 M
20251.1 M
2024978 K
20231.6 M
2022-2.7 M
2021-688 K
2020-861 K

About AngioDynamics Financial Statements

AngioDynamics investors utilize fundamental indicators, such as Net Interest Income, to predict how AngioDynamics Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Net Interest Income1.1 M1.2 M

Pair Trading with AngioDynamics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AngioDynamics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AngioDynamics will appreciate offsetting losses from the drop in the long position's value.

Moving together with AngioDynamics Stock

  0.63IL3 Integra LifeSciencesPairCorr

Moving against AngioDynamics Stock

  0.67DXCM DexCom IncPairCorr
  0.58HYB HOYAPairCorr
  0.55OM Outset MedicalPairCorr
The ability to find closely correlated positions to AngioDynamics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AngioDynamics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AngioDynamics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AngioDynamics to buy it.
The correlation of AngioDynamics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AngioDynamics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AngioDynamics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AngioDynamics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether AngioDynamics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AngioDynamics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Angiodynamics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Angiodynamics Stock:
Check out the analysis of AngioDynamics Correlation against competitors.
To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Will Health Care Equipment & Supplies sector continue expanding? Could AngioDynamics diversify its offerings? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every AngioDynamics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(0.67)
Revenue Per Share
7.466
Quarterly Revenue Growth
0.09
Return On Assets
(0.05)
Return On Equity
(0.15)
Investors evaluate AngioDynamics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating AngioDynamics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause AngioDynamics' market price to deviate significantly from intrinsic value.
Understanding that AngioDynamics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether AngioDynamics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, AngioDynamics' market price signifies the transaction level at which participants voluntarily complete trades.